Spots Global Cancer Trial Database for Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
Official Title: Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
Study ID: NCT05088161
Conditions
Interventions
Study Description
Brief Summary: In this study, we will use high-throughput proteomics techniques to search for biomarkers of post-operative prognosis of pancreatic cancer in samples of patients who have been diagnosed with pancreatic cancer through bioinformatics analysis.
Detailed Description: This study plan from the affiliated hospital of Qingdao university collected 20 cases of patients with pancreatic cancer pathological tissue samples and clinical data, including clinical diagnostic information, laboratory tests, imaging examination results and other information data), through high-throughput proteomic technology in pancreatic cancer pathological finding biomarkers, the bioinformatics analysis to explore the prognosis biomarkers.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Phase I Clinical Research Center, Qingdao, Shandong, China
Contact Details
Name: Yu Cao, Doctor
Affiliation: the study director of phase I clinical research center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
